Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Clinical trial NCT03821792 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03821792
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Carcinoma Prostate Adenocarcinoma Prostate Carcinoma Metastatic in the Bone Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2019-07-22
Primary completion: 2026-10-11
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.